Read all posts

Harvard prevention trial studies tau, Alzheimer’s other protein

CHICAGO (Reuters) - Alzheimer's researchers at Harvard for the first time are scanning the brains of healthy patients for the presence of a hallmark protein called tau, which forms toxic tangles of nerve fibers associated with the fatal disease.

Read the article on U.S.

Dr. Sears Comments:

Dr. Barry Sears

The only trouble in looking for tau proteins is that levels of tau do not seem to be the driving force behind dementia. It appears the inflammation reduction is the key. The only anti-inflammatory “drug” that can easily pass the blood-brain barrier is high-dose fish oil.

Leave a Reply

Your email address will not be published. Required fields are marked *